Exane Derivatives’s BioMarin Pharmaceuticals BMRN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q2 | $122K | Sell |
|
|||||
|
2022
Q1 | $146K | Sell |
|
|||||
|
2021
Q4 | $186K | Sell |
|
|||||
|
2021
Q3 | $215K | Sell |
|
|||||
|
2021
Q2 | $250K | Buy |
|
|||||
|
2021
Q1 | $214K | Buy |
|
|||||
|
2020
Q4 | $163K | Buy |
|
|||||
|
2020
Q3 | $55.4K | Hold |
|
|||||
|
2020
Q2 | $89.8K | Hold |
|
|||||
|
2020
Q1 | $61.5K | Sell |
|
|||||
|
2019
Q4 | $79.3K | Hold |
|
|||||
|
2019
Q3 | $60.2K | Sell |
|
|||||
|
2019
Q2 | $76.9K | Buy |
|
|||||
|
2019
Q1 | $79.7K | Buy |
|
|||||
|
2018
Q4 | $39.8K | Buy |
|
|||||
|
2018
Q3 | $1.26K | Sell |
|
|||||
|
2018
Q2 | $125K | Sell |
|
|||||
|
2018
Q1 | $108K | Buy |
|
|||||
|
2017
Q4 | $2.85K | Sell |
|
|||||
|
2017
Q3 | $16K | Buy |
|